| 2D Structure | |
| CID | 71412 |
| IUPAC Name | 2-hydroxy-5-[1-hydroxy-2-(4-phenylbutan-2-ylamino)ethyl]benzamide;hydrochloride |
| InChI | InChI=1S/C19H24N2O3.ClH/c1-13(7-8-14-5-3-2-4-6-14)21-12-18(23)15-9-10-17(22)16(11-15)19(20)24;/h2-6,9-11,13,18,21-23H,7-8,12H2,1H3,(H2,20,24);1H |
| InChI Key | WQVZLXWQESQGIF-UHFFFAOYSA-N |
| Canonical SMILES | None |
| Isomeric SMILES | None |
| Molecular Formula | C19H25ClN2O3 |
| Molecular Weight | 364.9 |
| synonyms | ['Labetalol hydrochloride', '32780-64-6', 'Labetalol HCL', 'Labrocol', 'ScH 15719W', 'AH 5158A', 'Ibidomide hydrochloride', 'Sch-15719W', '1GEV3BAW9J', 'AH-5158A', 'NSC-290312', 'DTXSID0044654', 'AH-5158A HYDROCHLORIDE', 'SCH-15719W HYDROCHLORIDE', 'DTXCID8024654', 'NSC290312', '5-(1-Hydroxy-2-((1-methyl-3-phenylpropyl)amino)ethyl)salicylamide monohydrochloride', 'Benzamide, 2-hydroxy-5-(1-hydroxy-2-((1-methyl-3-phenylpropyl)amino)ethyl)-, monohydrochloride', '5-[1-Hydroxy-2-[(1-methyl-3-phenylpropyl)amino]ethyl]salicylamide monohydrochloride', 'Labetalol Hydrocloride', 'Hydrochloride, Labetalol', 'Labetalol HCl in Dextrose', 'Labetalol HCl in Sodium Chloride', 'LABETALOL HYDROCHLORIDE IN DEXTROSE', 'LABETALOL HYDROCHLORIDE IN SODIUM CHLORIDE', '2-Hydroxy-5-((1RS)-1-hydroxy-2-((1RS)-1-methyl-3-phenylpropylamino)ethyl)benzamide monohydrochloride 2-Hydroxy-5-((1RS)-1-hydroxy-2-((1SR)-1-methyl-3-phenylpropylamino)ethyl)benzamide monohydrochloride', '251-211-1', 'Amipress', 'Presdate', 'Trandate', 'Normodyne', 'Labetalol (hydrochloride)', '2-Hydroxy-5-(1-hydroxy-2-((4-phenylbutan-2-yl)amino)ethyl)benzamide hydrochloride', 'MFCD00057663', 'Benzamide,2-hydroxy-5-[1-hydroxy-2-[(1-methyl-3-phenylpropyl)amino]ethyl]-, hydrochloride(1:1)', '32780-64-6 (HCl)', 'MLS000069666', '2-hydroxy-5-[1-hydroxy-2-(4-phenylbutan-2-ylamino)ethyl]benzamide;hydrochloride', 'Labetalol (hydrochloride) (Standard)', 'AH-5158 hydrochloride;Sch-15719W', 'Pressalolo', 'SMR000058463', 'Ipolab', 'rac-Labetalol Hydrochloride', '2-hydroxy-5-[1-hydroxy-2-(4-phenylbutan-2-ylamino)ethyl]benzamide hydrochloride', '5-(1-Hydroxy-2-((1-methyl-3-phenylpropyl)amino)ethyl)salicylamide hydrochloride', '5-[1-Hydroxy-2-[(1-methyl-3-phenylpropyl)amino]ethyl]salicylamide hydrochloride', '2-Hydroxy-5-[1-hydroxy-2-[(1-methyl-3-phenylpropyl)amino]ethyl]benzamide hydrochloride', '2-Hydroxy-5-(1-hydroxy-2-(4-phenylbutan-2-ylamino)ethyl)benzamide HCl', 'CCRIS 1086', 'SR-01000000209', 'EINECS 251-211-1', 'UNII-1GEV3BAW9J', '72487-34-4', 'NSC 290312', '2-hydroxy-5-(1-hydroxy-2-(4-phenylbutan-2-ylamino)ethyl)benzamide hydrochloride', '2-Hydroxy-5-(1-hydroxy-2-[(1-methyl-3-phenylpropyl)amino]ethyl)benzamide hydrochloride', 'Normodyne (TN)', 'Trandate (TN)', 'Prestwick_290', 'EINECS 276-694-6', 'Labeolol hydrochloride', 'Labetalol hydrochloride [USAN:USP:JAN]', 'La.beta.lol hydrochloride', 'Opera_ID_1625', 'Benzamide,monohydrochloride', 'NCGC00016810-01', 'Salicylamide, hydrochloride', 'CAS-32780-64-6', 'Salicylamide, 5-(1-hydroxy-2-((1-methyl-3-phenylpropyl)amino)ethyl)-, hydrochloride', 'SCHEMBL41230', 'MLS001148626', 'MLS002222197', 'SPECTRUM1503243', 'CHEBI:6344', 'orb1310699', 'CHEMBL1200323', 'SCHEMBL29710409', 'HY-B1108R', 'GLXC-06704', 'HMS1568H16', 'HMS1922M13', 'HMS5083I05', 'MSK000466A', 'Pharmakon1600-01503243', 'BCP13886', 'EX-A4940', 'HY-B1108', 'LABETALOL HYDROCHLORIDE [MI]', 'Tox21_110623', 'Tox21_302725', 'Tox21_500687', 'CCG-40314', 'Labetalol hydrochloride (JP17/USP)', 'LABETALOL HYDROCHLORIDE [JAN]', 'NSC758438', 's4291', 'LABETALOL HYDROCHLORIDE [USAN]', 'AKOS015895575', 'AC-1389', 'AH-5158', 'CS-4706', 'FL61512', 'LABETALOL HYDROCHLORIDE [MART.]', 'LABETALOL HYDROCHLORIDE [VANDF]', 'LP00687', 'NC00571', 'NSC-758438', 'SS-4219', 'LABETALOL HYDROCHLORIDE [USP-RS]', 'LABETALOL HYDROCHLORIDE [WHO-DD]', 'NCGC00094044-01', 'NCGC00094044-02', 'NCGC00094044-03', 'NCGC00094044-04', 'NCGC00094044-05', 'NCGC00256847-01', 'NCGC00261372-01', '(R*,R*)-(1)-5-(1-Hydroxy-2-((1-methyl-3-phenylpropyl)amino)ethyl)salicylamide monohydrochloride', 'DB-048265', 'CS-0694914', 'EU-0100687', 'LABETALOL HYDROCHLORIDE [ORANGE BOOK]', 'NS00087824', 'SW196595-3', 'LABETALOL HYDROCHLORIDE [EP MONOGRAPH]', 'D00600', 'LABETALOL HYDROCHLORIDE [USP MONOGRAPH]', 'Labetalol hydrochloride, >98% (TLC), powder', 'NORMOZIDE COMPONENT LABETALOL HYDROCHLORIDE', 'SR-01000000209-2', 'SR-01000000209-7', 'Q27252396', '2-Hydroxy-5-(1-hydroxy-2-((4-phenylbutan-2-yl)amino)ethyl)benzamide HCl', 'Labetalol hydrochloride, European Pharmacopoeia (EP) Reference Standard', 'Labetalol hydrochloride, United States Pharmacopeia (USP) Reference Standard', '2-hydroxy-5-[1-hydroxy-2-[(1-methyl-3-phenyl-propyl)amino]ethyl]benzamide;hydrochloride', 'Labetalol Hydrochloride, Pharmaceutical Secondary Standard; Certified Reference Material', 'Benzamide, 2-hydroxy-5-[1-hydroxy-2-[(1-methyl-3-phenylpropyl)amino]ethyl]-, hydrochloride (1:1)'] |
From Pubchem